Pulmonary endarterectomy in a 12-year-old boy with multiple comorbidities
Tom Verbelen1, Bjorn Cools2, Zina Fejzic3
1Department of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium.
Insights
Pulmonary endarterectomy is a feasible and well-tolerated treatment for pediatric chronic thromboembolic pulmonary hypertension (CTEPH), even with comorbidities. Early surgical consideration improves outcomes for children with CTEPH.
Area of Science:
- Cardiology
- Pediatric Surgery
- Pulmonary Medicine
Background:
- Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious condition in children.
- Early diagnosis and intervention are crucial for improving patient prognosis.
Observation:
- A 10-year-old boy with multiple comorbidities presented with symptoms of severe pulmonary hypertension.
- Initial medical management with anticoagulation, antibiotics, and oxygen provided temporary relief.
- Despite progressive symptoms and severe right ventricular dysfunction, the patient was deemed inoperable in his country of residence.
Findings:
- Pulmonary endarterectomy was successfully performed in a 12-year-old boy with severe CTEPH and comorbidities.
- Post-surgery, significant improvements were observed in mean pulmonary artery pressure (mPAP) and cardiac output.
- The patient experienced a remarkable recovery, returning to normal activities without supplemental oxygen within months.
Implications:
- This case demonstrates the feasibility and efficacy of pulmonary endarterectomy in young pediatric patients with CTEPH.
- CTEPH should be strongly considered in children with risk factors such as hypercoagulable states or a history of thromboembolism.
- Timely surgical referral is essential, as it represents the only potentially curative treatment and delays may worsen prognosis.
Abstract:
A 10-year-old boy, with multiple comorbidities presented with fever, exertional dyspnea, fatigue and an obliterated brachiocephalic and inferior caval vein. Chronic thromboembolic pulmonary hypertension (CTEPH) was diagnosed. Nadroparine, antibiotics and supplemental oxygen were successfully started. Aged 12 years, supplemental oxygen was permanently needed with progressive exertional dyspnea and fatigue. In the country of residence the patient was considered as inoperable. The right ventricle was severely dilated, hypocontractile and hypertrophic. Mean pulmonary artery pressure (mPAP) was 79 mmHg and cardiac output 2.2 L/min. Pulmonary endarterectomy was uneventful. Four days later, mPAP was 33 mmHg and cardiac output 6.4 L/min. Three months later the boy restarted his education without supplemental oxygen. Six months after surgery right ventricular size and function and mPAP (14 mmHg) were normal. We demonstrated that pulmonary endarterectomy in young aged children is feasible and well-tolerated, even in the presence of severe co-morbidities. CTEPH should be an important diagnostic consideration in symptomatic children with a known hypercoaguable state, a history of thrombo-embolism or venous catheter placement, and/or a diagnosis of pulmonary hypertension. Hesitating to refer children for surgical consideration, or attempting to treat them by medication, only postpones the single potentially curable treatment and may worsen their prognosis.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care


